Pharmacology
Summary
Absence seizures, predominantly observed in children, are typified by sudden, ephemeral lapses in consciousness. These episodes manifest as staring, rhythmic blinking, or minor clonic jerks in the upper extremities. Remarkably, post-seizure, individuals usually have no memory of the event and promptly return to their baseline state of awareness and behavior. An essential diagnostic tool, the electroencephalogram (EEG), distinctly portrays these seizures through the emergence of generalized 3 Hz spike-wave complexes on EEG.
Ethosuximide operates by inhibiting the T-type calcium channels located in thalamic neurons, and is specifically for absence seizures. This modulation curtails the sustained rhythmic discharges in the thalamus, effectively averting the inception of absence episodes. Among ethosuximide's notable side effects are GI symptoms such as pain, nausea, and vomiting, coupled with potential lethargy or fatigue. If ethosuximide therapy is ineffective or intolerable, other antiepileptics like valproate or lamotrigine may be considered.
Lesson Outline
Don't stop here!
Get access to 133 more Pharmacology lessons & 13 more medical school learning courses with one subscription!
FAQs
Ethosuximide works as an antiepileptic drug by blocking the T-type Ca2+ channels in the thalamus. This is a critical action in preventing the occurrence of absence seizures as it disrupts the aberrant neuronal activity causing the seizures.
Absence seizures are characterized by sudden, brief lapses in awareness which can be accompanied by staring, blinking, or clonic jerks. Despite their sudden onset, these seizures are typically brief. They can be identified on an EEG by the manifestation of 3 Hz spike wave complexes.
Ethosuximide can cause several side effects, most commonly gastrointestinal distress, including pain, nausea, and vomiting. Some patients may also experience lethargy or fatigue after taking the medication.
Valproate, which primarily works by blocking sodium and t-type calcium channels, and lamotrigine, which inhibited voltage-dependent sodium channels, can also be effective against absence seizures.
Ethosuximide is often a first-line therapy for absence seizures due to its efficacy and relatively mild side effects. It's a narrow spectrum antiepileptic drug, so it's particularly targeted towards the treatment of absence seizures. However, if ethosuximide therapy is ineffective or intolerable, other medications like valproate or lamotrigine may be considered. The overarching goal of antiepileptic therapy is to reduce the frequency and severity of seizures, and improve the patient's quality of life.
MCAT® is a registered trademark of the Association of American Medical Colleges. The United States Medical Licensing Examination (USMLE®) is a joint program of the Federation of State Medical Boards (FSMB®) and National Board of Medical Examiners (NBME®). NAPLEX® is a registered trademark of the National Association of Boards of Pharmacy. PANCE© is a registered trademark of the National Commission on Certification of Physician Assistants. NCLEX® is a registered trademark and service mark of the National Council of State Boards of Nursing, Inc. None of the trademark holders are endorsed by nor affiliated with Sketchy or this website.
